CML: Preventing chemo-induced vascular toxicity
Pediatric News ,
PARIS – Two tyrosine kinase inhibitors (TKI) used in the treatment of chronic myeloid leukemia (CML) – nilotinib (Tasigna) and…
PARIS – Two tyrosine kinase inhibitors (TKI) used in the treatment of chronic myeloid leukemia (CML) – nilotinib (Tasigna) and…
PARIS — Two tyrosine kinase inhibitors (TKI) used in the treatment of chronic myeloid leukemia (CML) — nilotinib (Tasigna) and…